Discover 573 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 573
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
for
Death; Neonatal, Morbidity;Newborn
Location: Oklahoma City OK, Ada OK, Elk City OK, Altus OK,
Sponsor: Mayo Clinic
Sex: All
Age: 0+
Code: NCT06087224
Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Oklahoma City OK, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Location: Oklahoma City OK, Dallas TX, Kansas City MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase 2, Recruiting
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Oklahoma City OK, Overland Park KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05886036
Phase 2, Recruiting
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Oklahoma City OK, Conroe TX, Houston TX, Sugar Land TX,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT06388018
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
for
Recurrent or Refractory Solid Tumors, Ewing Sarcoma,
Location: Oklahoma City OK, Dallas TX, Lubbock TX, Milwaukee WI,
Sponsor: South Plains Oncology Consortium
Sex: All
Age: 1 - 20
Code: NCT02013336
Phase 1, Recruiting
Low Level Tragus Stimulation in Acute Decompensated Heart Failure
for
Acute Decompensated Heart Failure
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 70+
Code: NCT02898181
Recruiting
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
for
Obesity in Pregnancy, Labor Complication
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: Female
Age: 15 - 45
Code: NCT06488781
Phase 2, Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Oklahoma City OK, Houston TX, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase 2, Recruiting
Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness
for
Alcohol Misuse, Homeless
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18+
Code: NCT06821295
Phase 2, Phase 3, Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Oklahoma City OK, Dallas TX, Houston TX, San Antonio TX,
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
for
Acute Stroke, Ischemic Stroke, Stroke
Location: Oklahoma City OK, Tulsa OK, Wichita KS, Houston TX,
Sponsor: DiaMedica Therapeutics Inc
Sex: All
Age: 18 - 70+
Code: NCT05065216
Phase 2, Phase 3, Recruiting
Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
for
Asthma
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 70+
Code: NCT02241265
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Oklahoma City OK, Salina KS, Hays KS, Topeka KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase 3, Recruiting
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
for
Advanced Alveolar Soft Part Sarcoma,
Location: Oklahoma City OK, Houston TX, Columbus OH,